About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Orchid Pharma Ltd.
BSE Code
524372
ISIN Demat
INE191A01027
Book Value
270.15
NSE Code
ORCHPHARMA
Dividend Yield %
0.00
Market Cap
46509.42
P/E
102.88
EPS
8.91
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
12-Jun-2026
847.00
933.50
847.00
917.00
35161
31840733
11-Jun-2026
832.00
874.35
831.95
852.45
22021
18802592
10-Jun-2026
861.75
870.40
848.00
850.35
3049
2615041
09-Jun-2026
845.70
861.85
839.60
859.40
3399
2897694
08-Jun-2026
843.05
882.45
835.50
845.75
8262
7131497
05-Jun-2026
840.50
846.60
827.30
841.40
1465
1225034
04-Jun-2026
830.00
860.50
826.95
834.35
5741
4857040
03-Jun-2026
810.25
852.75
810.25
834.40
10401
8715745
02-Jun-2026
782.35
835.90
772.15
825.25
11588
9453988
01-Jun-2026
807.70
822.45
774.00
776.75
5383
4322133
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Scores
|
Policies of JFSL
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
|
Rights and obligation
|
SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.